✦ LIBER ✦

Phase II clinical study of modified FOLFOX7 (intermittent oxaliplatin administration) plus bevacizumab in patients with unresectable metastatic colorectal cancer—CRAFT study

✍ Scribed by Tohru Tezuka, Chikuma Hamada, Hideyuki Ishida, Mitsuru Ooshiro, Hiroshi Matsuoka, Shingo Kawasaki, Hideyuki Mishima, Kotaro Maeda, Junichi Sakamoto, Keiji Koda…show all 10hide

Book ID: 120963380
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 425 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9982-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase 1B Study of Dulanermin in Combin

A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

✍ Wainberg, Zev A.; Messersmith, Wells A.; Peddi, Parvin F.; Kapp, Amy V.; Ashkena 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 608 KB

Front-line Bevacizumab in combination wi

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

PEAK: A Randomized, Multicenter Phase II

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

✍ Schwartzberg, L. S.; Rivera, F.; Karthaus, M.; Fasola, G.; Canon, J.-L.; Hecht, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 520 KB

6098 POSTER CRAFT Trial-Result From Mult

6098 POSTER CRAFT Trial-Result From Multicenter Phase II Study of Modified FOLFOX7 (Combination Chemotherapy of Infusional 5-FU/l-Leucovorin and Intermittent Oxaliplatin) With Bevacizumab in the First-line Therapy of Colorectal Cancer

✍ Ishibashi, K.; Koda, K.; Oshiro, M.; Matsuoka, H.; Baba, H.; Ishida, H.; Katoh, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Prospective phase II study of neoadjuvan

Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis

✍ Jun Ho Ji, Se Hoon Park, Jeeyun Lee, Tae Won Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 228 KB

First-line sunitinib plus FOLFIRI in Jap

First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study

✍ Yasushi Tsuji; Taroh Satoh; Akihito Tsuji; Kei Muro; Motoki Yoshida; Tomohiro Ni 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB